Panas
Cynthia Dawn Walker Panas, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20130332110 | NON-ITERATIVE MAPPING OF CAPPED CYLINDRICAL ENVIRONMENTS - Method for mapping capped cylindrical environments. The method uses an algorithm for creating an environment map through 3D data segmentation and fitting of right planar capped cylinders. The algorithm implementing the method of the invention offers improved robustness, accuracy and speed over existing segmentation and fitting methods. The improved properties of the invention are achieved through the use of a Gauss map, 3D histogram and shape knowledge driven segmentation. Performance was demonstrated on a variety of cylinders using simulated data. | 12-12-2013 |
Dean Panas, New Berlin, WI US
Patent application number | Description | Published |
---|---|---|
20090190298 | FUNCTIONAL AND ORNAMENTAL COVER FOR FLASH MEMORY STICK DEVICE - A memory stick cover is configured to be used by a consumer for receiving and protecting the connector of a memory stick when the memory stick is being transported and otherwise not in use. The memory stick cover is removable from the connector end and placed over the opposite end of the memory stick when the memory stick is connected to a computer. The memory stick cover of the present invention is somewhat of a novelty item as it may be configured of a moldable material such as rubber. Alternatively, it may consist of a hard-covered material with a rubber or other pliable material insert, the insert being configured to receive and protect the male connector of the memory stick. | 07-30-2009 |
Michael W. Panas, Westborough, MA US
Patent application number | Description | Published |
---|---|---|
20140363465 | MYCOBACTERIAL VACCINE VECTORS AND METHODS OF USING THE SAME - Mycobacterium bovis BCG is a potent stimulator of the cellular immune response and has potential as a recombinant vaccine vector. Disclosed are BCG strains that generate greater MHC class I presentation of a transgenic protein, relative to the unmutated parental strain, and that improve a recipient's CD8+ T cell response against the transgenic protein following vaccination. The mycobacterial constructs and their respective t/ansposon mutant BCG strains exhibit increased immunogenicity that is several times greater than responses generated by the parental strain and other existing modified rBCG strains. Furthermore, upon introducing the SIV gag gene into these novel strains, we observed that these strains primed for increased CD8+ T cell responses in a heterologous prime/boost regimen, comparable to levels generated by plasmid DNA vaccines. Creation of a second generation rBCG vector that may be utilized as a vaccine vector for immunizing against a variety of pathogens. | 12-11-2014 |